Novel p53/p130 Axis in Bladder Tumors

Urology

Volumn 70, Issue 3, 2007, Pages 608-612

  Mudryj, Maria ^a,b   Reay, Elizabeth ^b   Beckett, Laurel ^b   Dandekar, Satya ^b   deVere White, Ralph ^b   Gandour Edwards, Regina ^b,c  

^a VA NORTHERN CALIFORNIA HEALTH CARE SYSTEM   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN E; KI 67 ANTIGEN; PROTEIN BCL 2; PROTEIN P130; PROTEIN P27; PROTEIN P53; RETINOBLASTOMA PROTEIN;

ADULT; AGED; APOPTOSIS; ARTICLE; BLADDER TUMOR; CANCER STAGING; CELL PROLIFERATION; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NICK END LABELING; PRIORITY JOURNAL; PROTEIN EXPRESSION; STAINING; TISSUE MICROARRAY;

ADULT; AGED; AGED, 80 AND OVER; APOPTOSIS; CARCINOMA, TRANSITIONAL CELL; CELL DIVISION; CELL NUCLEUS; CYCLIN E; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYTOPLASM; FEMALE; HUMANS; KI-67 ANTIGEN; MALE; MIDDLE AGED; NEOPLASM PROTEINS; NEOPLASM STAGING; PROTO-ONCOGENE PROTEINS C-BCL-2; RETINOBLASTOMA-LIKE PROTEIN P130; TUMOR SUPPRESSOR PROTEIN P53; URINARY BLADDER NEOPLASMS;

EID: 34648832129     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2007.05.002     Document Type: Article

References (25)

1. Jemal A., Siegel R., Ward E., et al. Cancer statistics, 2007. CA Cancer J Clin 57 (2007) 43-66
2. Droller M.J. Bladder cancer: state-of-the-art care. CA Cancer J Clin 48 (1998) 269-284
3. Smith N.D., Rubenstein J.N., Eggener S.E., et al. The p53 tumor suppressor gene and nuclear protein: basic science review and relevance in the management of bladder cancer. J Urol 169 (2003) 1219-1228
4. Quentin T., Henke C., Korabiowska M., et al. Altered mRNA expression of the Rb and p16 tumor suppressor genes and of CDK4 in transitional cell carcinomas of the urinary bladder associated with tumor progression. Anticancer Res 24 (2004) 1011-1023
5. Sgambato A., Migaldi M., Faraglia B., et al. Loss of P27Kip1 expression correlates with tumor grade and with reduced disease-free survival in primary superficial bladder cancers. Cancer Res 59 (1999) 3245-3250
6. Cordon-Cardo C., Wartinger D., Petrylak D., et al. Altered expression of the retinoblastoma gene product: prognostic indicator in bladder cancer. J Natl Cancer Inst 84 (1992) 1251-1256
7. Lipponen P.K., and Liukkonen T.J. Reduced expression of retinoblastoma (Rb) gene protein is related to cell proliferation and prognosis in transitional-cell bladder cancer. J Cancer Res Clin Oncol 121 (1995) 44-50
8. Classon M., and Harlow E. The retinoblastoma tumour suppressor in development and cancer. Nat Rev Cancer 2 (2002) 910-917
9. Korkolopoulou P., Christodoulou P., Konstantinidou A.E., et al. Cell cycle regulators in bladder cancer: a multivariate survival study with emphasis on p27Kip1. Hum Pathol 31 (2000) 751-760
10. Poyurovsky M.V., and Prives C. Unleashing the power of p53: lessons from mice and men. Genes Dev 20 (2006) 125-131
11. Del Pizzo J.J., Borkowski A., Jacobs S.C., et al. Loss of cell cycle regulators p27(Kip1) and cyclin E in transitional cell carcinoma of the bladder correlates with tumor grade and patient survival. Am J Pathol 155 (1999) 1129-1136
12. Richter J., Wagner U., Kononen J., et al. High-throughput tissue microarray analysis of cyclin E gene amplification and overexpression in urinary bladder cancer. Am J Pathol 157 (2000) 787-794
13. Donnellan R., and Chetty R. Cyclin E in human cancers. FASEB J 13 (1999) 773-780
14. Dhillon N.K., and Mudryj M. Cyclin E overexpression enhances cytokine-mediated apoptosis in MCF7 breast cancer cells. Genes Immun 4 (2003) 336-342
15. Lee S.H., and McCormick F. Downregulation of Skp2 and p27/Kip1 synergistically induces apoptosis in T98G glioblastoma cells. J Mol Med 83 (2005) 296-307
16. Lavin M.F., and Gueven N. The complexity of p53 stabilization and activation. Cell Death Differ 13 (2006) 941-950
17. Lang G.A., Iwakuma T., Suh Y.A., et al. Gain of function of a p53 hot spot mutation in a mouse model of Li-Fraumeni syndrome. Cell 119 (2004) 861-872
18. Smith E.J., Leone G., and Nevins J.R. Distinct mechanisms control the accumulation of the Rb-related p107 and p130 proteins during cell growth. Cell Growth Differ 9 (1998) 297-303
19. Lindeman G.J., Gaubatz S., Livingston D.M., et al. The subcellular localization of E2F-4 is cell-cycle dependent. Proc Natl Acad Sci USA 94 (1997) 5095-5100
20. Russo G., Zamparelli A., Howard C.M., et al. Expression of cell cycle-regulated proteins pRB2/p130, p107, E2F4, p27, and pCNA in salivary gland tumors: prognostic and diagnostic implications. Clin Cancer Res 11 (2005) 3265-3273
21. Mattioli E., Vogiatzi P., Sun A., et al. Immunohistochemical analysis of pRb2/p130, VEGF, EZH2, p53, p16(INK4A), p27(KIP1), p21(WAF1), Ki-67 expression patterns in gastric cancer. J Cell Physiol 210 (2007) 183-191
22. Macaluso M., Montanari M., Noto P.B., et al. Nuclear and cytoplasmic interaction of pRb2/p130 and ER-{beta} in MCF-7 breast cancer cells. Ann Oncol 17 suppl 7 (2006) vii27-vii29
23. Chestukhin A., Litovchick L., Rudich K., et al. Nucleocytoplasmic shuttling of p130/RBL2: novel regulatory mechanism. Mol Cell Biol 22 (2002) 453-468
24. Asher G., and Shaul Y. p53 proteasomal degradation: poly-ubiquitination is not the whole story. Cell Cycle 4 (2005) 1015-1018
25. Li M., Brooks C.L., Kon N., et al. A dynamic role of HAUSP in the p53-Mdm2 pathway. Mol Cell 13 (2004) 879-886